Tall stature and overgrowth syndromes

Overview & Definition

Tall stature is the mirror image of short stature in statistical terms — a height lying more than two standard deviations above the age- and sex-specific mean — but its clinical meaning is almost the opposite. Where short stature almost always earns an investigation, tall stature usually earns reassurance, because the great majority of tall children are healthy and reflect the genetic endowment of their parents. The skill is therefore not in detecting the tall child but in redistributing the few who carry a pathological cause out of the reassuring majority, and the redistribution rests on a structured assessment rather than on the height number alone. [6]

Familial tall stature is the commonest single cause. A child whose parents are both tall has a high mid-parental target height, grows at a normal velocity along a high centile, has a normal physical examination and body proportions, and a bone age that matches the chronological age. Constitutional advancement of growth is a closely related variant in which an early, self-limited growth spurt and slightly advanced bone age produce a child who is tall relative to peers in mid-childhood but reaches a final adult height within the normal range. Neither of these variants carries intellectual disability, dysmorphism, or tumour risk, and the clinical task is to document the evidence that confirms the variant rather than to investigate reflexively. [7]

The pathological causes demand a different posture, because each carries a consequence that reassurance would delay. Syndromic overgrowth disorders — Sotos, Beckwith-Wiedemann, Weaver, Simpson-Golabi-Behmel, and the Tatton-Brown-Rahman and related methylation-disorder family — pair excess growth with intellectual disability and, in several, a defined embryonal tumour risk. Growth-hormone excess produces gigantism in the open-epiphysis child and carries the cardiovascular and mass consequences of a pituitary adenoma. Chromosomal and hormonal causes, from Klinefelter syndrome to precocious puberty, reshape the growth trajectory and the final height, and several are treatable. The general paediatrician sits at the gate, deciding who is reassured and who is referred. [8] [4]

References12Show ledgerHide ledger

1. [1]Ocansey S, Cole TRP, Rahman N, et al. Sotos Syndrome. GeneReviews, 1993.PMID 20301652
2. [2]Brioude F, Kalish JM, Mussa A, et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome. Nat Rev Endocrinol, 2018.PMID 29377879
3. [3]Gibson WT, Hood RL, Zhan SH, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet, 2012.PMID 22177091
4. [4]Lui JC, Baron J. Epigenetic Causes of Overgrowth Syndromes. J Clin Endocrinol Metab, 2024.PMID 37450557
5. [5]Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. The revised Ghent nosology for the Marfan syndrome. J Med Genet, 2010.PMID 20591885
6. [6]Caro R, Savel P, Moss PI. Evaluation of Short and Tall Stature in Children. Am Fam Physician, 2025.PMID 40531152
7. [7]Sada V, Puliani G, Feola T, et al. Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review. J Endocrinol Invest, 2024.PMID 37891382
8. [8]Tatton-Brown K, Loveday C, Yost S, Clarke M, Ramsay E, Zachariou A, Elliott A, Wylie H, Ardissone A, Rittinger O, Stewart F, Temple IK, Cole T; Childhood Overgrowth Consortium, Mahamdallie S, Seal S, Ruark E, Rahman N. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability. Am J Hum Genet, 2017.PMID 28475857
9. [9]Maas SM, Vansenne F, Kadouch DJ, Ibrahim A, Bliek J, Hopman S, Mannens MM, Merks JH, Maher ER, Hennekam RC. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A, 2016.PMID 27419809
10. [10]Argente J, Tatton-Brown K, Lehwalder D, Pfäffle R. Genetics of Growth Disorders-Which Patients Require Genetic Testing? Front Endocrinol (Lausanne), 2019.PMID 31555216
11. [11]Shen W, Heeley JM, Carlston CM, et al. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies. Am J Med Genet A, 2017.PMID 28941052
12. [12]Russo S, Milani D, Meossi C, et al. Beckwith-Wiedemann spectrum (BWSp): an update on diagnosis, management, and follow-up from the Italian BWSp Register. Ital J Pediatr, 2025.PMID 41126215